Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Bioorg Med Chem Lett. 2015 Mar 12;25(21):4961–4969. doi: 10.1016/j.bmcl.2015.03.012

Figure 1.

Figure 1

Comparison of structures of (A) human hepcidin, (B) minihepcidin PR73, (C) inactive disulfide-bond cyclized analog cycloDTHFPI(CIF-CONHCH2CH2S-), and (D) bioactive disulfide-bond cyclized analog cyclo(CDTHFPIC)IF-CONH2.